Talphera (TLPH) EBIT Margin Growth (5y) (2016 - 2025)
Talphera (TLPH) EBIT Margin Growth (5y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Talphera | 90.63 Mn | 90.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -34.15 Mn |
| Mar 31, 2025 | -669,430.00 |
| Dec 31, 2023 | 26,650.00 |
| Sep 30, 2023 | -35,393.00 |
| Jun 30, 2023 | -69,432.00 |
| Mar 31, 2023 | 236,887.00 |
| Mar 31, 2022 | -164,674.00 |
| Dec 31, 2021 | -40.86 Mn |
| Sep 30, 2021 | -27,090.00 |
| Jun 30, 2021 | -207,705.00 |
| Mar 31, 2021 | -150,732.00 |
| Dec 31, 2020 | -81,697.00 |
| Sep 30, 2020 | -70,665.00 |
| Jun 30, 2020 | 18,847.00 |
| Mar 31, 2020 | 219,264.00 |
| Dec 31, 2019 | 205,574.00 |
| Sep 30, 2019 | -212,093.00 |
| Jun 30, 2019 | 1.51 Mn |
| Mar 31, 2019 | 384,538.00 |
| Dec 31, 2018 | -180,202.00 |